In a 59-year-old man with six months of progressive weakness, difficulty lifting objects, mild dysarthria, proximal upper-extremity weakness with biceps hyperreflexia, quadriceps atrophy (more pronounced on the left) and absent patellar tendon reflexes, what is the most likely diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amyotrophic Lateral Sclerosis (ALS)

The most likely diagnosis is amyotrophic lateral sclerosis (ALS), given the combination of upper motor neuron signs (hyperreflexia) and lower motor neuron signs (atrophy, weakness, absent reflexes) occurring simultaneously in a progressive pattern over six months.

Clinical Reasoning

This 59-year-old man presents with a classic mixed upper and lower motor neuron syndrome that is pathognomonic for ALS:

Upper Motor Neuron Signs Present:

  • Hyperreflexia of biceps tendons bilaterally - This indicates corticospinal tract involvement 1
  • Mild dysarthria - Suggests bulbar upper motor neuron involvement

Lower Motor Neuron Signs Present:

  • Quadriceps atrophy and weakness (asymmetric, worse on left)
  • Absent patellar reflexes - Indicates anterior horn cell loss
  • Proximal upper extremity weakness
  • Progressive course over 6 months

Why This Pattern Confirms ALS:

The simultaneous presence of hyperreflexia (upper motor neuron) in the arms alongside absent reflexes (lower motor neuron) in the legs with progressive weakness is the hallmark of ALS 1, 2. ALS typically presents with hypertonicity and hyperreflexia from upper motor neuron degeneration combined with muscle fasciculations, weakness, and atrophy from lower motor neuron degeneration 1.

The 6-month progressive course fits perfectly - ALS patients typically reach maximum disability within weeks to months, with disease onset being acute or subacute 2. The median survival is 3-4 years after symptom onset 1.

Why Other Diagnoses Are Excluded:

Guillain-Barré Syndrome (#2): Definitively ruled out because:

  • GBS presents with areflexia throughout - reflexes are decreased or absent in almost all patients 3
  • GBS reaches maximum disability within 2 weeks, not 6 months 3
  • GBS has a monophasic course with recovery, not progressive deterioration 3
  • This patient has hyperreflexia in upper extremities, which contradicts GBS

Myasthenia Gravis (#5): Excluded because:

  • MG causes fatigable weakness without atrophy
  • Reflexes remain normal in MG
  • No sensory changes or reflex abnormalities occur 4
  • This patient has prominent atrophy and reflex changes

Multiple Sclerosis (#4): Not consistent because:

  • MS would show CNS involvement with sensory symptoms
  • The pattern of pure motor involvement with both UMN and LMN signs simultaneously is not typical of MS
  • MS doesn't cause the degree of muscle atrophy seen here

Hypothyroidism (#3): Completely incompatible:

  • Hypothyroid myopathy causes generalized weakness without reflex changes of this pattern
  • No upper motor neuron signs occur
  • Reversible with treatment

Critical Diagnostic Features in ALS:

The asymmetric presentation (quadriceps weakness more pronounced on left) is typical - weakness in ALS can be asymmetrical or predominantly proximal or distal 3. The proximal-to-distal progression of muscle weakness is well-documented in ALS 5.

Common Pitfall to Avoid:

In atypical ALS presentations, particularly those with only motor signs, normal or even exaggerated reflexes might be observed in some muscle groups while others show areflexia 3. This patient demonstrates exactly this pattern - hyperreflexia in biceps but absent patellar reflexes - which is pathognomonic for ALS when combined with progressive weakness and atrophy.

Expected Disease Progression:

  • Bulbar involvement develops in most patients during disease course 2
  • Dysphagia occurs in 48-86% of ALS patients 2
  • Nearly all patients manifest bulbar involvement in advanced disease 2
  • Progressive respiratory failure is the primary cause of death 2

The answer is #1: Amyotrophic Lateral Sclerosis.

Related Questions

Since [date] I have progressive lower extremity weakness and muscle atrophy, with hip pain on standing that improves when sitting; what urgent evaluation and workup is recommended?
What is the most likely diagnosis and recommended acute management for a 60-year-old male with worsening weakness, clumsiness, mild dysarthria, left-sided proximal weakness, and hyperreflexia of the biceps and quadriceps?
What is the appropriate differential diagnosis and work‑up for a woman who, since age 31, has episodic weakness, tingling, and incoordination of the hands and arms that are triggered by exercise and worsened by heat?
In an 87-year-old patient with new onset lower extremity weakness, what is the recommended immediate evaluation and management?
What is the differential diagnosis for a 54-year-old male presenting with muscle cramps, palpitations, fatigue, and insomnia?
Which of the following is the most common cause of sinus tachycardia: tissue hypoxia, metabolic hyperoxygenation, drowning, or beta‑blocker overdose?
In a patient who has already received a Microlax (sodium phosphate) enema and digital disimpaction attempts, should oral polyethylene glycol (Laxido) be started now or wait until after the planned enema or manual removal tomorrow?
What evidence supports the use of capsaicin cream for treating nausea and vomiting?
How should pelvic congestion syndrome be diagnosed and treated in a reproductive‑age woman with chronic dull pelvic pain that worsens with standing, intercourse, or prolonged sitting and a history of multiple pregnancies or varicose veins?
For a 62-year-old woman with compensated metabolic‑dysfunction cirrhosis, what is the appropriate surveillance strategy for hepatocellular carcinoma, including abdominal ultrasound frequency and alpha‑fetoprotein (AFP) testing?
How does amitriptyline improve gastrointestinal symptoms such as abdominal pain, dyspepsia, and altered bowel habits?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.